Sergio Buenestado-Serrano

Mr. Sergio Buenestado-Serrano

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2021 in Journal of Travel Medicine
Verified
Journal Article
Open access
PDF file
AMAndrea Molero-Salinas
Andrea Molero-Salinas
CRCarla Rico-Luna
Carla Rico-Luna
CLCarmen Losada
Carmen Losada
SBSergio Buenestado-Serrano
Sergio Buenestado-Serrano
VGVíctor Manuel de la Cueva García
Víctor Manuel de la Cueva García
DGDarío García-de-Viedma
Darío García-de-Viedma
Hundred and ninety-six travellers with negative-COVID-19-tests prior to departure tested positive, on arrival at Madrid (April/June 2021), from a total of 45 211 travellers tested (0.43%). Viral loads (Ct: 20.3) were higher compared to the general population (Ct: 27.09). Our data reveal weaknesses in pre-departure testing and alert about high-viral-load-SARS-CoV-2 carriers in intercontinental flights.


22 May 2026 in Microbial Genomics
Verified
Journal Article
Open access
SSSheri M. Saleeb
Sheri M. Saleeb
AMAndrea Marcos-Abellán
Andrea Marcos-Abellán
MFMaría Teresa Cabezas Fernández
María Teresa Cabezas Fernández
SVSilvia Vallejo-Godoy
Silvia Vallejo-Godoy
MMMiguel Martínez-Lirola
Miguel Martínez-Lirola
DGDarío García-de-Viedma
Darío García-de-Viedma
Whole-genome sequencing (WGS) has enhanced precision to predict antimicrobial resistance and track transmission in Mycobacterium tuberculosis (MTB). Due to the slow-growing nature of MTB, genomic results are unavoidably delayed; however, few efforts have been made to accelerate them by performing WGS directly on respiratory specimens. Most culture-free efforts in the literature have focused on the acceleration of resistance prediction. The present study provides further evidence to the only preceding study aiming to accelerate the precise delineation of transmission, coupling culture-free WGS to a surveillance programme. Our study is distinguished from its predecessor by being the first to apply flexible nanopore sequencing for the purpose of further accelerating the process. A total of 71 sputa were selected for the study, in which we only applied a procedure to deplete human DNA, thus avoiding other costly and cumbersome alternatives based on capture baits. Optimal results (>90% of genome covered, mean coverage >45× and >70% genome covered >20×) were obtained from 33.8% of the cases, which allowed the corresponding cases to be ruled in or out of transmission clusters, close to their diagnosis. A further 12.6% of the samples yielded suboptimal results (15.5%–90.92% at >10×), which could also be exploited thanks to our rescue pipeline; the rationale was to attempt to identify, from the suboptimal sequences, the informative SNPs that are markers for relevant transmission clusters in our population. The rescue pipeline facilitated pre-allocation of new cases to pre-existing clusters and moreover enabled the specification of genomic relationships between new cases and preceding ones in the cluster. In summary, the present study has demonstrated that epidemiologically valuable information can be obtained directly from sputum in approximately half of the samples analysed. This study represents a new advancement in the pursuit of enhancing faster comparative genomics, at diagnosis, for epidemiological applications.